Stelios Papadopoulos - Insider Trading & Ownership

Entity
Individual
Location
3 Somerset Drive South, Great Neck, NY
Summary
The estimated net worth of Stelios Papadopoulos is at least $37.6M dollars as of June 4, 2024. Stelios Papadopoulos is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $26.6M. Stelios Papadopoulos is the Director of BIOGEN INC. and owns shares of BIOGEN INC. (BIIB) stock worth about $9.5M. Stelios Papadopoulos is the Director of Regulus Therapeutics Inc. and owns shares of Regulus Therapeutics Inc. (RGLS) stock worth about $1.57M.
All Insider Reports
All Insider Reports

Ownership of Stelios Papadopoulos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $26.6M -$240K -0.9% May 31, 2024
BIIB BIOGEN INC. Director $9.5M Jun 15, 2022
RGLS Regulus Therapeutics Inc. Director $1.57M May 20, 2024

Insider Transactions Reported by Stelios Papadopoulos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.